Coach DrépanoCoach Drépanoles clés de l'autonomie

Les publications derrière Trévor.

Les travaux publiés qui fondent chaque fonction, pour vérifier par vous-même.

Publications scientifiques

  1. Piel FB, Rees DC, DeBaun MR, Nnodu O, Ranque B, Thompson AA, et al. (dont Issom DZ). Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. Lancet Haematol 2023;10(8):e633-e686. doi:10.1016/S2352-3026(23)00096-0
  2. Issom DZ, Hardy-Dessources MD, Romana M, Hartvigsen G, Lovis C. Toward a conversational agent to support the self-management of adults and young adults with sickle cell disease: usability and usefulness study. Frontiers in Digital Health 2021;3:600333. doi:10.3389/fdgth.2021.600333
  3. Issom DZ, Henriksen A, Woldaregay AZ, Rochat J, Lovis C, Hartvigsen G. Factors influencing motivation and engagement in mobile health among patients with sickle cell disease in low-prevalence, high-income countries: qualitative exploration of patient requirements. JMIR Human Factors 2020;7(1):e14599. doi:10.2196/14599
  4. Issom DZ, Rochat J, Hartvigsen G, Lovis C. Preliminary evaluation of a mHealth coaching conversational artificial intelligence for the self-care management of people with sickle-cell disease. Studies in Health Technology and Informatics 2020;270:1361-1362. doi:10.3233/SHTI200442
  5. Issom DZ, Zosso A, Ehrler F, Wipfli R, Lovis C, Koch S. Exploring the challenges and opportunities of eHealth tools for patients with sickle cell disease. Studies in Health Technology and Informatics 2015;216:898.

493 citations, indice h 9 (Google Scholar, septembre 2026) · PubMed · Google Scholar

Voir toutes les publications, par thème
Drépanocytose et autogestion numérique (9)
  1. Piel FB, Rees DC, DeBaun MR, et al. (dont Issom DZ). Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. Lancet Haematol 2023;10(8):e633-e686. doi:10.1016/S2352-3026(23)00096-0
  2. Issom DZ. Digital health interventions to empower people with sickle cell disease: toward patient-led design. In Sickle Cell Disease, IntechOpen, 2022.
  3. Issom DZ, Hardy-Dessources MD, Romana M, Hartvigsen G, Lovis C. Toward a conversational agent to support the self-management of adults and young adults with sickle cell disease: usability and usefulness study. Frontiers in Digital Health 2021;3:600333. doi:10.3389/fdgth.2021.600333
  4. Issom DZ, Henriksen A, Woldaregay AZ, Rochat J, Lovis C, Hartvigsen G. Factors influencing motivation and engagement in mobile health among patients with sickle cell disease in low-prevalence, high-income countries. JMIR Human Factors 2020;7(1):e14599. doi:10.2196/14599
  5. Issom DZ, Rochat J, Hartvigsen G, Lovis C. Preliminary evaluation of a mHealth coaching conversational artificial intelligence for the self-care management of people with sickle-cell disease. Stud Health Technol Inform 2020;270:1361-1362. doi:10.3233/SHTI200442
  6. Issom DZ, Kanter J. Mind over matter: one person's journey from patient to change-maker. The Hematologist 2018;15(5).
  7. Issom DZ, Hartvigsen G, Bonacina S, Koch S, Lovis C. User-centric eHealth tool to address the psychosocial effects of sickle cell disease. Stud Health Technol Inform 2016;225:627-628.
  8. Issom DZ, et al. Meeting sickle cell patients' unmet needs with eHealth tools: a preliminary study. Scandinavian Conference on Health Informatics, 2015.
  9. Issom DZ, Zosso A, Ehrler F, Wipfli R, Lovis C, Koch S. Exploring the challenges and opportunities of eHealth tools for patients with sickle cell disease. Stud Health Technol Inform 2015;216:898.
Engagement, données personnelles et santé mobile (6)
  1. Woldaregay AZ, Issom DZ, Henriksen A, et al. Motivational factors for user engagement with mHealth apps. Stud Health Technol Inform 2018;249:151-157.
  2. Woldaregay AZ, Henriksen A, Issom DZ, et al. User expectations and willingness to share self-collected health data. Stud Health Technol Inform 2020;270:894-898. doi:10.3233/SHTI200290
  3. Bradway M, Woldaregay AZ, Issom DZ, et al. mHealth: where is the potential for aiding informal caregivers? Stud Health Technol Inform 2021;281:885-890. doi:10.3233/SHTI210306
  4. Henriksen A, Issom DZ, Woldaregay AZ, et al. Dataset of motivational factors for using mobile health applications and systems. Data in Brief 2023;50:109589. doi:10.1016/j.dib.2023.109589
  5. Rochat J, Gaudet-Blavignac C, Del Zotto M, et al. (dont Issom D). Citizens' participation in health and scientific research in Switzerland. Stud Health Technol Inform 2020;270:1098-1102. doi:10.3233/SHTI200332
  6. Issom DZ, et al. Mobile applications for people with diabetes published between 2010 and 2015. Diabetes Management 2015;5(6).
Santé publique et maladies non transmissibles (2)
  1. Sureshkumar S, Mwangi KJ, Gathecha G, et al. (dont Issom D). Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya. Pan Afr Med J 2023;44:153. doi:10.11604/pamj.2023.44.153.38616
  2. Sureshkumar S, Mustapha F, Yusoff H, et al. (dont Issom D). An online survey of the perceptions of clinical and non-clinical professionals on healthcare for non-communicable diseases and COVID-19 measures during the pandemic in Malaysia. Int J Public Health 2023;68:1605861. doi:10.3389/ijph.2023.1605861
Informatique médicale hospitalière et chaîne transfusionnelle (5)
  1. Albadri R, Perelli I, Freitas F, Waldvogel S, Issom DZ. Designing an interoperable intelligent agent for the blood transfusion chain in Geneva, Switzerland. Stud Health Technol Inform 2026;336:428-432. doi:10.3233/SHTI260191
  2. Bouzo Cueva J, Perelli I, Freitas F, Waldvogel S, Issom DZ. Designing a digital twin for equitable blood donation logistics in Geneva. Stud Health Technol Inform 2026;336:1795-1796. doi:10.3233/SHTI260538
  3. Lovis C, Gaudet-Blavignac C, Chevrier R, Robert A, Issom D, Foufi V. Big data, intelligence artificielle et blockchain pour les nuls. Rev Med Suisse 2018;14(617):1559-1563.
  4. Issom DZ, Hagry C, Wodia Mendo L, Seng H, Ehrler F, Lovis C. Challenges and issues of geolocation in clinical environment. Stud Health Technol Inform 2012;180:447-451.
  5. Ehrler F, Issom D, Lovis C. Technological choices for mobile clinical applications. Stud Health Technol Inform 2011;169:83-87.

Distinctions et médias

2021

Distinction «Qualité de la vie» de la Fondation Dalle Molle
Trevor, le coach de la drépanocytose, distingué lors du concours 2021 de la Fondation Dalle Molle pour la qualité de la vie.

2021

«Le projet Trevor primé», Hôpitaux Universitaires de Genève
Actualité institutionnelle des HUG consacrée à la distinction et au projet.

2023

Planète Santé, entretien, 1er mars 2023
«Les innovations doivent tenir compte du monde tel qu'il est», par Laetitia Grimaldi.

2025

Pulsations, le magazine des HUG, avril 2025
«J'ai toujours voulu comprendre ma maladie», par Geneviève Ruiz.

2026

RTS, CQFD, 23 juin 2026
«Drépanocytose: vivre avec une maladie génétique du sang», avec la Dre Lara Chavaz.